SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-040851
Filing Date
2024-05-08
Accepted
2024-05-08 16:05:28
Documents
13
Period of Report
2024-05-07
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea0205550-8k_chinapharma.htm   iXBRL 8-K 27921
  Complete submission text file 0001213900-24-040851.txt   203646

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cphi-20240507.xsd EX-101.SCH 3024
3 XBRL LABEL FILE cphi-20240507_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cphi-20240507_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0205550-8k_chinapharma_htm.xml XML 3779
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34471 | Film No.: 24925823
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)